Biospark Biotechnology

Biospark Biotechnology is a synthetic biology company that specializes in the development of high-performance enzymes and microbial cell factories. The company utilizes a proprietary high-throughput screening and directed evolution platform to design and manufacture high-value molecules for the pharmaceutical, nutraceutical, and cosmetic industries. Their core business involves replacing traditional, energy-intensive chemical synthesis with sustainable biocatalytic processes. Biospark's product portfolio includes anti-aging compounds such as nicotinamide mononucleotide and various pharmaceutical intermediates. By integrating advanced computational biology with automated laboratory workflows, the company aims to accelerate the commercialization of bio-based products.